Last updated: April 20, 2023
Sponsor: Tel-Aviv Sourasky Medical Center
Overall Status: Active - Recruiting
Phase
N/A
Condition
Lymphoma
Treatment
N/AClinical Study ID
NCT04957693
0264-18
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18 years old
- Patient sex - male and female
- Diagnosis with indolent lymphoma in low-grade lymphoma (follicular lymphoma (FL),marginal zone lymphoma MZL), as assessed by Groupe d'Etude des Lymphomes Folliculaires (GELF) criteria
- Lack of need and non treatable patients at the time of diagnosis
- Existence of detailed medical information about physical activity and dietary habits
- Patients who have signed an informed consent form to participate in the study.
Exclusion
Exclusion Criteria:
- Need for therapeutic intervention
- Administration of chemotherapy and / or monoclonal antibodies or immunomodulatorypreparation
- Chronic inflammatory or infectious disease
- Another malignant disease
- Pregnant women, special populations - children and incapacitated of judgment
Study Design
Total Participants: 40
Study Start date:
July 05, 2021
Estimated Completion Date:
October 01, 2025
Connect with a study center
Tel-Aviv Sourasky Medical Center
Tel Aviv,
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.